Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Clinician's RoundtablePersonalized CRC Screening: Applying Real-World Evidence to Test Selection
Brian P. McDonough, MD, FAAFP
David A. Johnson, MD, FACG, FACP
Rethinking Who Qualifies for Advanced IBD Therapy
GI InsightsRethinking Who Qualifies for Advanced IBD Therapy
Gil Melmed, MD
Aligning Medical and Patient Goals in IBD Treatment
GI InsightsAligning Medical and Patient Goals in IBD Treatment
Gil Melmed, MD
ADHD Is Linked to a Broad Burden of GI Symptoms
NeuroFrontiersADHD Is Linked to a Broad Burden of GI Symptoms
Microbiome Signature May Help Predict Infliximab Response in Crohn’s Disease
GI InsightsMicrobiome Signature May Help Predict Infliximab Response in Crohn’s Disease
Diet-Microbiome Links Diverge in Crohn’s Disease and Ulcerative Colitis
GI InsightsDiet-Microbiome Links Diverge in Crohn’s Disease and Ulcerative Colitis
- advertisement
Playing the Long Game: Improving Durable Control in IBD
CME/CEPlaying the Long Game: Improving Durable Control in IBD
Anita Afzali, MD, MPH, MHCM, FACG, AGAF
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
CME/CEIBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD
Ugo Iroku, MD, MHS
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Setting the Stage: Why Rethinking IBD Care Matters Now
MinuteCE®Setting the Stage: Why Rethinking IBD Care Matters Now
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Ugo Iroku, MD, MHS
Michael Dolinger, MD, MBA
- advertisement
Epithelial Cytokines Drive Type 2 Inflammation in Eosinophilic Esophagitis
Innovations In MedicineEpithelial Cytokines Drive Type 2 Inflammation in Eosinophilic Esophagitis
Jennifer Caudle, DO, FACOFP
Kathryn Peterson, MD
John Leung, MD
Setting Treatment Goals in Ulcerative Colitis: Real-Patient Provider Discussion
Medical Industry FeatureSetting Treatment Goals in Ulcerative Colitis: Real-Patient Provider Discussion
David T. Rubin, MD
Adam Benjamin
What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Jennifer Caudle, DO, FACOFP
Syma Iqbal, MD
Bowel Urgency as a Key Symptom in Ulcerative Colitis
Medical Industry FeatureBowel Urgency as a Key Symptom in Ulcerative Colitis
Ehsan Navabi, MD
Christie Morrison, NP
Bowel Urgency as a Key Symptom in Crohn’s Disease
Medical Industry FeatureBowel Urgency as a Key Symptom in Crohn’s Disease
Partha Nandi, MD
Amy Stewart, CRNP
Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Innovations In MedicineNavigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Charles Turck, PharmD, BCPS, BCCCP
Andrew Freeman, MD, FACC, FACP
- 10/12/2026
- 10/08/2026
- 10/01/2026
- 10/01/2026
- 10/01/2026